The takeover of local drug manufacturer, Ayrton Drugs, by South African Pharmaceutical giant, Adcock Ingram, is expected to bring about some changes at the boardroom level to reflect the new shareholding structure. But company officials say this is about the only major change that may happen as a result of the takeover. Ayrton Managing Director Benson Agyepong tells Joy Business the company’s objectives will remain the same, adding that the company is still focused on becoming the leading pharmaceutical giant in West Africa. Adcock last week finally completed a deal to take up majority holding in Aryton. This follows an Adcock offer to acquire 51 percent of Ayrton’s shares which was oversubscribed by 65.5 per cent. Source: Joy Business/Myjoyonline.com/Ghana